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ReviewGlossary
Bioinformatics: the application of molecular biology as an information science,
especially involving the use of computers in genomics research.
DNA resequencing: sequencing an individual’s specific DNA segment, for which
sequence information is already available from one or more other individuals.
DNA sequencing: this term encompasses biochemical methods for determin-
ing the order of the nucleotide bases, adenine, guanine, cytosine and thymine,
in a DNA oligonucleotide.
Epigenome: a form of the genome that has been modified, without alteration in
DNA sequence, by changes like DNA methylation and/or histone modifications.
The epigenome can differ among different cell types of the same individual.
Thus, an organism can have several epigenomes, but only one genome. The
epigenome controls the differential expression of genes in specific cells.
EST (expressed sequence tag): a short sub-sequence of a transcribed, spliced,
nucleotide sequence, produced by one-shot sequencing of a cloned mRNA (i.e.
sequencing several hundred base pairs from an end of a cDNA clone taken
from a cDNA library).
Exon: a sequence of DNA that codes information for protein synthesis that is
transcribed into spliced messenger RNA.
Flow cell: a reaction chamber containing templates tethered to a solid surface,
to which nucleotides and reagents are iteratively applied and removed by
washing for ‘sequencing by synthesis’ (SBS); most second- and third-
generation sequencers use flow cells.
Genomics: the study of the entire genome of an organism; structural genomics
includes whole-genome sequencing, whereas functional genomics aims to
determine the functions of all genes.
Metagenome: the genetic material present in an environmental sample that
consists of the genomes of the many individual organisms.
MicroRNAs (miRNA): single-stranded RNA molecules of 21–23 nucleotides in
length. miRNAs are encoded by genes that are transcribed into untranslatable
non-coding RNAs (ncRNA), which regulate gene expression at the mRNA level.
Non-Sanger sequencing systems: systems that do not make use of Sanger’s
dideoxy termination method, which up until a few years ago was the only DNA
sequencing method used in all sequencing systems.
Pan-genome: the total gene repertoire in a given species; it includes the ‘core
genome’, which is shared by all individuals, the ‘dispensible genome’, which is
shared by some individuals, and the ‘unique genome’, which is unique to an
individual.
Personal Genome Project (PGP): an initiative aiming to publish complete
genomes and medical records of several volunteers, to be used for
personalized medicine.
SAGE (serial analysis of gene expression): a technique used to produce a
snapshot of the mRNA population in a sample of interest.
Single-pass sequencing: sequencing each individual DNA template only once,
resulting in error-prone sequencing reads, depending on the type of sequencer
used. However, if the single-pass sequencing covers the given genome or a
part of the genome many times due to the presence of multiple copies of the
sequence in the library, the sequences might overlap. Thus, when assembled
to generate a contiguous sequence, most errors are removed.
Transcriptome: the set of all mRNA molecules or ‘transcripts’ that are
produced either in all cells or in a particular cell type of an organism.
Two-pass sequencing: sequencing each individual template twice, giving two
reads from the same position on the same strand to reduce the error rate. In the
first pass, a template is sequenced as usual (pass 1); the primers are then
melted off and the same template is sequenced a second time (pass 2). It
requires covalent attachment of template strands to the surface in a stable and
biocompatible fashion, and enables high accuracy in sequencing, because only
sequences occurring in both reads are accepted as correct.During the current genomics revolution, the genomes of
a large number of living organisms have been fully
sequenced. However, with the advent of new sequen-
cing technologies, genomics research is now at the
threshold of a second revolution. Several second-gener-
ation sequencing platforms became available in 2007,
but a further revolution in DNA resequencing technol-
ogies is being witnessed in 2008, with the launch of the
first single-molecule DNA sequencer (Helicos Bios-
ciences), which has already been used to resequence
the genome of the M13 virus. This review discusses
several single-molecule sequencing technologies that
are expected to become available during the next few
years and explains how they might impact on genomics
research.
Introduction
Since the onset of genomics research in the mid-1990s,
whole-genome sequencing has been undertaken for a large
number of prokaryotes and eukaryotes. However, the
initial enthusiasm and euphoria for whole-genome sequen-
cing activity has now given way to a demand for large-scale
whole-genome resequencing (see Glossary) or the sequen-
cing of target regions and/or metagenomes and pan-gen-
omes (see Glossary), which require an increased
sequencing speed and reduced costs [1,2]. With this in
mind, in 2004, the National Human Genome Research
Institute of the National Institutes of Health (NIH–
NHGRI) announced a total of US$70 million in grant
awards for the development of DNA sequencing (see Glos-
sary) technologies that would reduce the cost of sequencing
the human genome fromUS$ 3  109, the amount spent on
the public Human Genome Project, to US$103 by 2014
(www.genome.gov/12513210). In October 2006, the X Prize
Foundation (Santa Monica, CA, USA) announced a US$10
million ‘Archon X Prize for Genomics’ to the first private
effort that could sequence 100 human genomes in 10 days
for less than US$10 000 per genome (http://genomics.
xprize.org/genomics/archon-x-prize-for-genomics). These
incentives have contributed to an explosion of research
activity in the development of new DNA sequencing tech-
nologies.
Further impetus for developing new DNA sequencing
technologies came from the emerging field of personal
genomics (see Glossary), which aims to study variationsZero-mode waveguides (ZMWs): sub-wavelength optical nanostructures, 50–
200 nm in size, used as devices for focal volume confinement.
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Box 1. Personal genome projects launched during 2005–
2008
Personal Genome Project (PGP)
In January 2006, George Church of Harvard Medical School
launched PGP (see Glossary) to develop a context for genome–
phenotype relationships. In the first instance, the genomes of 10
volunteers are being sequenced under ‘Genome 10’ or ‘PGP10’. This
project will expand to 100 000 volunteers in 2008.
Yanhuang Project
In April 2007, a large-scale whole-genome sequencing project,
described as ‘The Yanhuang Project’, was inaugurated in China. This
project will involve sequencing the entire genomes of 100 Chinese
individuals over three years. Once this project is completed, the
Beijing Genomics Institute (BGI) aims to sequence the genomes of
1000 more people, including members of ethnic groups from other
Asian countries.
1000 Genomes Project
A large multigenome international project, which aims to sequence
the genomes of 1000 individuals, was formally unveiled in January
2008. This project is a collaboration among the National Human
Genome Research Institute of the US National Institutes of Health
(NIH–NHGRI; Bethesda, MD USA), the Wellcome Trust Sanger
Institute (Hinxton, UK) and the BGI (Shenzhen, China). It has been
informally called the ‘1000 Genomes Project’ and will most probably
include the hundreds of individuals who also participated in the
International HapMap Project – an ongoing study of genetic
diversity – in addition to other individuals.
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personal genomes have been fully sequenced, and the
genome sequences of Craig Venter and JamesWatson have
been the only ones published [3,4]. Nevertheless, initiat-
ives are underway to further increase the freely available
sequence data for a large number of individual human
genomes, as proposed in the Personal Genome Project and
other similar projects launched recently (Box 1) [5,6].
To meet the increased sequencing demands, several
non-Sanger ultra-high-throughput sequencing systems
became commercially available in 2007 [7–12] (for non-
Sanger sequencing systems, see Glossary). These were
described as ‘second generation’ or ‘next generation’
sequencing systems, and included the following: Genome
Sequencer 20/FLX (commercialized by 454/Roche); ‘Solexa
1G’ (later named ‘Genome Analyzer’ and commercialized
by Illiumina/Solexa); SOLiDTM system (commercialized
by Applied Biosystems); and Polonator G.007 (commercia-
lized by Dover Systems). These developments have sig-
nificantly reduced the cost of sequencing – from 1 cent for
10 bases to 1 cent for 1000 bases – and have simul-
taneously yielded an increase in DNA sequencing speed.
As a result, several commercial genotyping services [e.g.
Knome, DeCode, 23andMe and Navigenics (http://
www.technologyreview.com/Biotech/20926/)] have alsoTable 1. A comparison of new-generation DNA sequencing platfor
Features Second-generation sequen-
cers
Third-generati
454-FLX Solexa SOLiD Helicos tSMS
Read-length (bp) 240–400 35 35 30
Cost/human genome (US$) 1 000 000 60 000 60 000 70 000
Run time (h/Gb) 75 56 42 12
Ease of use Difficult Difficult Difficult Easyappeared on the market. These companies provide ser-
vices to examine the genome of a person at as many as one
million sites for US$1,000 to US$2,500. Future services
might include the sequencing of whole genomes of indi-
vidual humans, if there is a demand. However, there is
also an attempt to regulate these gene tests, particularly
in the states of New York and California, where gene test
firms are being asked to obtain permits and conduct these
tests only on the advice of a physician (http://tinyurl.
com/55zzk8; http://tinyurl.com/5qgnr9).
Another non-Sanger DNA sequencing approach is the
use of single-molecule sequencing (SMS), which only
became available in 2008. This approach has been
described as a ‘third generation’ or ‘next-next generation’
sequencing technology. It is anticipated that SMS will be
much faster and cheaper, so that researchers in the near
future should be able to pursue new scientific enquiries
that are currently not possible owing to the prohibitive cost
of sequencing. Whether or not SMS will fulfill this promise
is debatable; compared with the earlier methods men-
tioned above, a significant reduction in sequencing costs
has not yet been demonstrated for the only commercially
available SMS technology, which is provided by Helicos
Biosciences (Table 1).
Nevertheless, additional major efforts are underway to
develop novel SMS technologies, which will be discussed
below. In addition, much work is being done to address the
outstanding issues that have become apparent during the
development of these second- and third- generation
sequencing technologies. Most of these outstanding issues
(e.g. short read-lengths, higher error-rates, and the diffi-
culty of managing massive amounts of data) are actually
common to both second- and third-generation sequencing
technologies, and bioinformatics (see Glossary) tools are
being developed to deal with them. However, this article
focuses on the third-generation SMS technologies, the so-
called ‘next-next generation’. These systems will probably
constitute a significant fraction of future genomics
research efforts, mainly because they will significantly
reduce the cost and effort of sequencing in comparison
with second-generation technologies – despite the fact that
cost reductions continue to be made for second-generation
approaches. SMS technology should not necessarily be
considered as a panacea that can overcome all limitations
associated with earlier technologies, and it is unlikely that
it will completely replace all earlier sequencing technol-
ogies. Rather, it should be seen as another new and prom-
ising technology; the actual benefits and limitations of will
only become fully known after it has been used by a large
number of researchers. It currently appears that, in future,
SMS technologies will either be the dominant DNA
sequencing methods or co-exist with other technologies.m
on sequencers (single molecule-SBS)
PacBio SMRT Nanopore and modified forms ZS Genetics TEM
100 000 Potentially unlimited? Potentially unlimited?
Low Low Low
<1 >20 14
Easy Easy Easy
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The amplification of the target DNA by polymerase chain
reaction (PCR) is an integral step in all second-generation
sequencing technologies. However, it creates several pro-
blems, including the introduction of a bias in template
representation, and the introduction of errors during
amplification. Another problem associated with second-
generation sequencing technologies is ‘dephasing’ of the
DNA strands due to loss of synchronicity in synthesis (i.e.
different strands being sequenced in parallel). This can
lead to errors during sequencing. These limitations can be
largely overcome by SMS. This method was proposed as
early as 1989 by Keller and coworkers [13–15], and it has
since been realized in the laboratory through several
approaches, such as scanning probe microscopy, exonu-
clease sequencing, and sequencing by synthesis (SBS),
among others (Figure 1) [16–20]. However, it was only in
2008 that the first commercial SMS instrument was
launched. This system, developed by Helicos Biosciences,
is based on SBS. Other promising technologies, also using
the SBS principle, are likely to be commercially realized in
the near future. Two other novel and promising SMS
technologies include nanopore sequencing and trans-Figure 1. Two different approaches for SMS. (a) Exonuclease sequencing.
Enzymatic digestion is used to cleave one base at a time from a transcript that is
obtained by incorporation of fluorescent nucleotides; each base is cleaved by the
exonuclease and identified by single-molecule fluorescence spectroscopy. (b)
Sequencing by synthesis (SBS). The enzyme-catalyzed addition of each base is
monitored by a fluorescence signal (e.g. by using nucleotides with fluorescent
bases); in this method, each incorporated, labeled base is identified with the help
of a label – several methods for identification are available – and the label is
removed before another labeled base is incorporated. The four nucleotides are
either labeled with the same dye (e.g. Cy5 in the tSMS method of Helicos
Biosciences) or differently labeled (as in several other SBS methods). Reproduced
with permission from [20].
604mission electron microscopy (TEM). In contrast to SBS,
which relies on DNA synthesis, these systems involve no
chemistry,. The following section discusses some of these
SMS technologies.
Sequencing by synthesis
SBS on a solid surface in a flow cell (see Glossary) is the
DNA sequencing technique most commonly used in the
newest second- and third-generation sequencing systems.
The methods used in these systems are based on the
detection of individual nucleotides that are incorporated
during DNA synthesis. However, the techniques used for
labeling the nucleotides needed during DNA synthesis
differ from those used to determine the identity of incorp-
orated, labeled nucleotides. Below, we discuss three SMS
methods, based on SBS, that are likely to be commercia-
lized within the next few years, although several other
methods are also being tried.
True single-molecule sequencing (tSMSTM). This pro-
prietary method, which is commercialized by Helicos Bios-
ciences (Cambridge, MA, USA; http://www.helicosbio.
com/), has recently been used to resequence the entire
genome of the virus M13, which is approximately one
million times smaller than the human genome [21]. In this
technology, the target DNA is used for the construction of a
library of poly(dA)-tailed templates, which pair with
millions of poly(dT)-oligonucleotides that are anchored to
a glass cover-slip. The positions of each of these individual
poly(dT) oligos – and hence those of the respective paired
poly(dA)oligos – on the cover slip are determined by camera
imaging. The sequence of each poly(dA)-tailed fragment is
determined by adding nucleotides – each labeled with the
same cyanine dye Cy5 (a non-radioactive fluorescent dye) –
in a cyclic manner, one at a time. The incorporation of
nucleotides to each poly(dT) – or, indeed, the lack of
incorporation, depending upon complementarity – enables
faithful copying of the paired poly(dA)-tailed templates for
sequencing. The events of nucleotide incorporation are
imaged with a camera and used to obtain 30-base-long
sequences for each paired poly(dA)-tailed fragment
(Figure 2).
During the resequencing of theM13genomewith tSMS,
the error rate was reduced by performing a so-called ‘two-
pass’ sequencing (see Glossary). Misincorporations aris-
ing from dephasing, which results from asynchronous
synthesis of fragments, were circumvented by monitoring
each template molecule individually, thereby obviating
the need for synchronization between different template
molecules. This also enabled homopolymers to be read
accurately. By contrast, in other sequencingmethods, this
stage often leads to errors, because several molecules of a
particular nucleotide need to be incorporated in the same
cycle, when the enzyme encounters a homopolymer seg-
ment in a particular template. The other available tem-
plates with no homopolymers at that point of the sequence
use only a single molecule of the nucleotide during this
cycle, thus causing dephasing as a result of asynchronous
synthesis.
FRET-based approach. VisiGen Biotechnologies (Hous-
ton, TX, USA; http://www.visigenbio.com) is developing an
approach that uses fluorescence resonance energy transfer
Figure 2. The true single-molecule sequencing (tSMS) technology for DNA sequencing (Helicos Biosciences): (a) Schematic illustration showing the different steps involved
in tSMS (adapted from [65]). Four steps are shown in a clockwise order starting from top left: (i) incubation of flow cell (glass surface) with a dye-labeled nucleotide and its
incorporation; (ii) washing step to remove all unincorporated, labeled nucleotide molecules; (iii) camera imaging of the incorporated nucleotide through the attached Cy5
label (exciting at 647 nm); (iv) cleavage of dye–nucleotide linker to release the dye label. In the example shown, the incorporated nucleotide is cytosine (C) and the label is
cyanine Cy5 (F); (b) example for an image, and raw data obtained with tSMS technology (from http://www.helicosbio.com/Technology/TrueSingleMoleculeSequencing/
tabid/64/Default.aspx). The left picture shows an image of poly(dT) templates after incubation with a dye-labeled nucleotide. The inset on the right side shows a close-up
view of individual, single molecules, and the positions of three templates are marked (1–3) after the second cycle of incubation with labeled cytosine. Cytosine has been
incorporated at positions 1 and 2, but not at position 3. Figures reproduced with expressed permission of Helicos Biosciences Corporation.
Review Trends in Biotechnology Vol.26 No.11(FRET). In this system, the DNA sequence is read in real
time by monitoring a polymerase as it incorporates bases
into a DNA strand. The polymerase that is used contains a
donor fluorophore, and each nucleotide carries one of four
differently colored acceptor fluorophores. When a nucleo-
tide is incorporated, the proximity of donor and acceptor
fluorophores results in a FRET signal. This signal is
specific for the particular nucleotide incorporated at this
position, owing to its particular fluorophore label. After thenucleotide has been incorporated, the pyrophosphate con-
taining the fluorophore is released, thereby quenching the
signal and preparing the reaction for the next incorpora-
tion step. In this respect, the FRET-based SMS–SBS
approach might be regarded as an improvement on the
Helicos Biosciences tSMS technology, which requires the
cyclic addition of reagents, increasing the time and cost of
sequencing. VisiGen envisages that this approach will
reach themarket in 2009, and proposes a sequencing speed605
Review Trends in Biotechnology Vol.26 No.11of one million bases per second, which would mean that an
individual human genomemight be fully sequenced within
an hour.
SMRT sequencing. Single-molecule real-time sequen-
cing (SMRTTM) is another proprietary approach that is
being pursued by Pacific Biosciences (PacBio, Menlo Park,
CA, USA; http://www.pacificbiosciences.com). It involves
the use of so-called SMRT chips, eachmade up of a 100-nm-
thick metal film and containing thousands of zero-mode
waveguides (ZMWs; see Glossary), which are cavities of
10–50 nm in diameter. Within each ZMW, a DNA poly-
merase molecule is attached at the bottom and is visual-
ized as DNA is synthesized from a single-stranded DNA
molecule template (Figure 3) [22]. This reaction uses fluor-
ophore-labeled nucleotides, but the label is attached to the
phosphate group rather than to the base, and each nucleo-
tide is labeled with a different fluorophore. When a nucleo-
tide is incorporated during DNA synthesis, the attached
fluorophore lights up owing to laser-beam-mediated
illumination of a small detection volume (20 zeptoli-
ters = 20  1021 liters). This allows identification of each
incorporated nucleotide. During formation of the phospho-
diester bond, a nucleotide is held up in the detectionFigure 3. A schematic illustration representing the highly parallel optic system us
Biosciences). This method uses SMRT chips that contain thousands of zero-mode wav
(within the ZMWs) indicates nucleotide incorporation. This leads to a light flash that is se
determined. Figure reproduced from the document ‘Pacific Biosciences Technology Ba
606volume for a much longer time (milliseconds) than the
time (microseconds) needed for a nucleotide to diffuse in
and out of the detection volume. This increase in time
facilitates detection. During this detection process, the
other unincorporated nucleotides float in the dark in the
un-illuminated volume of ZMW and do not light up. As the
fluoropohore is attached to the phosphate group, it has to
be cleaved and released before the next nucleotide is
incorporated; the phosphate–dye complex is actually
released and quickly diffused out of the detection volume
after incorporation of the base. This set-up enables nucleo-
tides to be incorporated at a speed of ten bases per second,
giving rise to a chain of thousands of nucleotides in length
within minutes [23]. Importantly, simultaneous and con-
tinuous detection occurs across all of the thousands of
ZMWs that are located on the SMRT chip in real-time,
which facilitates the determination of thousands of
sequences, each sequence thousands of bases long. The
proof-of-concept for this technique has already been pro-
vided with the use of synthetic DNA templates of known
sequences.
PacBio anticipates selling their instruments in 2010 or
2011 at a price comparable to that of the ABI SOLiD ored in Single Molecule Real-Time (SMRT) DNA sequencing technology (Pacific
eguides (ZMWs). The presence of a fluorescent dye within the detection volume
parated into a spatial array, from which the identity of the incorporated base can be
ckgrounder’ (dated 2/2/2008), with expressed permission of Pacific Biosciences.
Review Trends in Biotechnology Vol.26 No.11Illumina ‘Genome Analyzer’. PacBio claims that, by 2013,
the technology will be able to give a ‘raw’ human genome
sequence in less than 3 min, and a complete high-quality
sequence in just 15 min (http://www.bio-itworld.com/
BioIT_Content.aspx?id=71746andamp;terms=Feb+12+
2008+Pacific+Biosciences).
Nanopore sequencing
The idea of nanopore sequencing was first conceived in
1989 by David Deamer of the University of California
(Santa Cruz, CA, USA) (http://www.futurepundit.com/
archives/000017.html). It is believed to have great promise,
andmany researchers in the field are eagerly waiting to see
the method working at a commercial scale. The basic out-
line of nanopore sequencing and some of its modifications
are discussed below.
Nanopore sequencing technology involves the use of a
very thin membrane that contains nanopores of 1.5–2 nm
indiameter. The target single-strandedDNA isplaced toone
side of the membrane, and a current is applied across the
nanopore [24]. The negatively charged DNA traverses
through the channel (the nanopore), towards the positive
charge, thus blocking the channel and generating a change
in the electrical conductance of themembrane. This, in turn,
leads to alternations in the current – in the range of picoam-
peres (pA)–and thesechangescanbemeasured inanelectric
circuit. This enables researchers to discriminate between
DNA molecules with different sequences (Figure 4). It has
been shown that the duration of the translocation of a
polynucleotide through a nanopore channel depends on its
sequence rather than on its length. Also, the nanopore
approach is able to distinguish betweenpolynucleotides that
are similar in length and composition (GC:AT ratio) but
which differ in sequence, even if at only a single position
(see [25,26] and references therein). However, despite enor-
mousactivity in this researcharea, thenanopore sequencing
approach has not been successfully used for the sequencing
of any significant number of nucleotides, and most appli-
cations are at the initial proof-of-concept stage. It is esti-
mated that the basic technologymight take at least another
five years to become commercially available.
Amajor drawback of the nanopore technology is that the
DNAmolecule might pass through the nanopore at a speed
that is too fast to enable the resolution of individual bases.
Therefore, efforts have been made to overcome this pro-
blem through modifications to the basic nanopore technol-
ogy desribed. Two of these specific modified nanopore-
sequencing methods will be discussed below.
‘Hybridization’-assisted nanopore sequencing (HANS).
This proprietary technique of the company NABsys
(http://nabsys.com/) was developed as a joint venture with
Brown University (both at Providence, RI, USA). It com-
bines nanopore sequencing with sequencing by hybridiz-
ation (SBH). The approach involves hybridizing each
molecule being sequenced with individual 6-mers from a
library that consists of all possible 6-mer nucleotide probes.
The resulting hybrid duplex DNA will pass through a
nanopore, and the resulting changes in current can be
measured and used for the detection of sites of hybridiz-
ation for each probe, because the effect of duplex DNA
hybrid segments on the current differs from that of asingle-stranded DNA molecule. This approach should give
a full-length map for each probe, such that sites of a large
number of 6-mer probes – each with known sequence –
encompassing the entire genome will be known and can be
used to determine the DNA sequence.
A technique similar to HANS has been developed by
Complete Genomics (Mountain View, CA, USA) in collab-
oration with BioNanomatrix (Philadelphia, PA, USA;
http://www.technologyreview.com/Biotech/20640). This
technology involves hybridization of 5-mer probes – in
groups of several differently labeled 5-mer probes at a time
– with the target DNA molecule, which is threaded into a
microfluidic device with channels of 100 nm in diameter.
The fluorescent label signals arising from the hybrid
duplex DNA segments are recorded using a special camera
– unlike HANS, which measures changes in current – and
provide the hybridization sites of all 5-mers used. The
process is repeated with different sets of 5-mers until
the entire target DNA molecule is covered. From these
sites, the complete target sequence is inferred. This can be
several thousand bases long, which is the major advantage
of this technique. The company claims that this technology
should become available within five years and that it
should cost only US$100 to sequence a human genome.
‘Design polymer’-assisted nanopore sequencing. This
technology has been developed by LingVitae (Oslo,
Norway; http://www.lingvitae.com/) and involves the con-
version of target DNA into a magnified form, the so-called
‘design polymer’. In this design polymer, each nucleotide of
the original DNA segment is replaced, one by one, by a
block of 20 nucleotides (using a proprietary technology).
The block itself consists of two types of 10-mers. These
blocks constitute a two-unit code (e.g. 01, in which 0
represents one 10-mer, and 1 represents the other 10-
mer within the 20 nucleotide block). Using this binary
code, the four bases of DNA can be encoded as 00, 01, 10
and 11. The 10-mers are optically detected with the use of
fluorescently labeled probes that hybridize with the codes
and which are unzipped during translocation through the
nanopores. The use of ‘design polymers’ and the ‘unzipping’
of probes will overcome the main problem of nanopore
sequencing – that a single 0.34-nm-long nucleotide passes
too fast through a nanopore – because the 20-nucleotide-
long coding units measure 7 nm, which is long enough to
allow for their discrimination. In this approach, the size of
the coding unit can range from 4 to 40 nucleotides.
Transmission electron microscopy for DNA sequencing
In this novel SMS platform, DNA sequences are read
directly with the help of a specialized transmission electron
microscope (TEM). This approach is being developed by ZS
Genetics (ZSG; North Reading, MA, USA; http://zsgenetics.
com/application/GenSeq/index.html), which has been
accepted as one of the competitors for the previously men-
tioned ‘Archon X Prize’. The details of this process were
presented for the first time at the recent CambridgeHealth-
tech Institute (CHI) Sequencing Conference in San Diego,
held from 23–24 April, 2008 (http://www.healthtech.com/
Conferences_Overview.aspx?id=60306andc=542).The tech-
nology involves the linearization of the target DNA
molecule, followed by synthesis of a complimentary strand,607
Figure 4. A schematic representation of the basic principle involved in nanopore sequencing. (a) Shown here is a surface view of a membrane with numerous nanopores.
(b) Shown is a cross-section of a part of the membrane, with a single-stranded DNA molecule traversing through a nanopore (not to scale). (c) Example of a peak profile
obtained as a result of current alterations (in pA) that occur when DNA is passing through the nanopore. (d) A hypothetical close-up of peaks that show expected changes in
current that would arise from a DNA with homopolymer segments, which are indicated by the presence of three distinct peaks. (e) A hypothetical example of a sequence
read-out that demonstrates single-base resolution of the technique based on minor but nevertheless detectable differences in current alterations. The extent of an observed
alteration in current can be correlated to a particular nucleotide passing through the nanopore.
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atoms, and the fourth base remains unlabeled. Given that
atoms such as C, O, N, H and P present in DNA have low
atomic number (Z = 1–15), natural DNA is transparent
when viewed with TEM. However, bases labeled with hea-
vier elements, with high Z values (e.g. iodine with Z = 53;
brominewithZ = 35),make theDNAheavier and, therefore,
visible under TEM. Thus, when the resulting complemen-
tary strand is observed under TEM, the four bases can be
discriminated by the size and intensity of dots representing
the four bases. ZSG claims to be able to generate read
lengths of 10 000 to 20 000 bases, with a rate of 1.7 billion
base pairs (equivalent to 400 million base pairs, with 4x
coverage) per day, and has already released images of a 23-
kb piece of DNA. The company claims that it will be able to
produce several-fold increases in the sequencing potential
with future improved versions of this technology.
Table 1 demonstrates a comparison of these recent SMS
technologies with the second-generation technologies,
which emerged in 2007 and still remain highly popular
among users. The table also demonstrates the advantages
that future SMS technologies promise to offer with regards
to time and cost.
Outstanding crucial issues
Despite these advantages, the SMS technologies share
with other recent technologies some of the limitations
and outstanding problems. These problems have been
widely discussed, and they need to be addressed before
any of these technologies can be extensively used in geno-
mics research in a user-friendly and cost-effective manner.
Bioinformatics: Assembly of short read-lengths, read
quality and the ability to produce paired-end reads
There has been much debate on the short read-lengths that
are typically generated by new sequencing technologies.
These cannot be easily used to reconstruct the much longer
de novo sequences needed for whole-genome sequencing
([27] and references therein). However, all the novel SMS
technologies – with the exception of the tSMS technology –
seem, at least in theory, to be able to yieldmuch longer read-
lengths. Therefore, although several algorithms have been
developed in attempts to overcome the limitations associ-
ated with short sequence read-lengths [28], short read-
lengths might not be a crucial problem for most of the novel
SMS technologies. However, some additional problems
arise, and these are receiving the increased attention of
bioinformaticians [27]. For instance, the sequence read-
quality, which causes errors, needs to be improved (besides
other reasons, kinetics of the enzyme could be one possible
reason for high error-rate, and efforts are being made to
improve the enzyme). Another problem is the inability to
generate paired-end sequence reads, which are needed to
determine the orientation and relative positions of contigs
during the assembly process. Finally, the management of
the enormous amount of data generated by the new sequen-
cing technologies is becoming a serious problem.
Enrichment of selected targets for resequencing
It has been recognized that, in most cases, resequencing
the whole genome might be unnecessary; rather, sequen-cing of only selected regions of the genome might be ad-
equate. For instance, in some cases, researchers might
need to sequence only the exons (see Glossary) in single-
copy genes or only the specific regions that are known to be
associated with certain diseases. In other cases, one might
be interested in studying genomic DNA sequences that are
methylated or associated with histone modifications, or
which are bound to proteins and/or RNA involved in regu-
lation of gene expression, or even those that are actively
involved in transcription at a particular time or in a given
space. Therefore, techniques are being developed to enrich
the target DNA in a desired manner, before it is used for
sequencing [29–32].
Conclusions and perspectives
The demand for large-scale DNA sequencing has dramatic-
ally increased in recent years. As a result, we are witnes-
sing the development of several mutually competitive DNA
sequencing systems that are much faster and cheaper and
which have a higher level of precision. These new systems
involve ultra-high-throughput sequencing of a large num-
ber of DNA fragments in parallel and include the following
three classes of sequencing systems: the first-generation
systems, which are based on the old, Sanger dideoxy
method, but which include improved technologies; the
second-generation systems, which are mainly based on
amplified SMS; and the third-generation systems, which
are based on true SMS (e.g. the tSMS technology of Helicos
Biosciences) and which do not involve amplification steps.
These ultra-high-throughput DNA sequencing technol-
ogies are already producing massive amounts of data at
an unprecedented rate, thus also making it necessary to
develop bioinformatics tools and hardware for storage,
retrieval and maintenance of data. Of the above methods,
the SMS technology has attracted particular attention and
excitement. However, it remains to be seen whether this
technology will become the dominant technology in the
future or whether it will co-exist with other second-gener-
ation technologies, because these latter methods have only
recently taken over from the first-generation technologies
as the market leaders.
Among the SMS technologies discussed in this review,
the tSMS technology developed by Helicos Biosciences is
the only technology that has already been commercialized
and which, through resequencing of the M13 genome, has
provided proof-of-concept. However, currently, this tech-
nology seems to be equally expensive, promises no more
than 30-base read-lengths, and has yet to be used to
sequence a complex genome of gigabase size. By contrast,
several other SMS technologies that are still under de-
velopment (e.g. SMRT, HANS, Design Polymer and TEM)
aremorepromisingwith regards to speed and cost andalso
have the potential to yield longer read-lengths. Thus,
short read-length, which is a serious limitation of the
second-generation sequencing instruments, might no
longer be an issue with future SMS instruments. The
projected cost and sequencing time in these technologies
also appears to be much lower. For instance, Complete
Genomics projects a human genome sequence for a
mere US$100 (http://www.technologyreview.com/Biotech/
20640/), and PacBio promises it within 3–15 min. Eminent609
Review Trends in Biotechnology Vol.26 No.11scientists, such as Craig Venter, the founder of ‘The Insti-
tute for Genomic Research’ (TIGR) and Celera Genomics, as
well as George Church of Harvard Medical School, have
expressed the view that such claims might indeed be rea-
listic (www.bio-itworld.com).
If the promises described in this revieware fulfilled, one
can look forward to yet another genomics revolution, in
which individual scientists in small laboratories can
undertake genomics research. This is a stark contrast to
themultinational, multi-billion dollar projects of the past.
Consequently, many more microbial, animal and plant
genomes could be sequenced to investigate how genomes
evolved [33–39]. The sequencing of increasing numbers of
metagenomes can lead to environmental clues in terms of
diverse and novel DNA sequences occurring in each indi-
vidual environment [40,41]. Also, sequencing of pan-gen-
omes (see Glossary) will allow identification of ‘unique
sequences’, ‘core sequences’ and ‘dispensable sequences’ in
the genome of an individual species [42,43]. Similarly,
sequencing of genomes of different species within a genus
will allow a study of variation among genomes within a
genus [44,45], and resequencing the human genome will
permit study of copy number variations (CNVs) and struc-
tural variations (SVs) associated with several human
diseases [46,47]. Enormous activity would also be
expected in the areas of functional genomics; for example,
the development of additional EST–SAGE (expressed
sequence tags–serial analysis of gene expression; seeGlos-
sary) data, and the analysis of transcriptomes, epigen-
omes and microRNA (see Glossary), as witnessed recently
[48–56]. Several recent studies on transcriptome analysis
in yeasts, Arabiopsis and mouse used the so-called
‘mRNA-Seq’ method of analysis using Solexa/SOLiD sys-
tems. These analyses indicated that the new sequencing
technologies might perhaps replace microarray technol-
ogy, which until now has been considered extremely
powerful for expression studies [57–61]. Future SMS tech-
nologies will certainly also have an impact on this area of
genomics research.
However, it should be noted that, although SMS is a
promising technology that draws a lot of attention, various
groups are simultaneously developing other ultra-high-
throughout, low-cost sequencing technologies that use both
the Sanger method and amplicative non-Sanger methods
[62–64]. It is therefore possible that SMS technology will
co-exist with other sequencing technologies – including
even the Sanger method. The above developments in
sequencing technologies will, however, create work for
bioinformaticians, because data management will be a
challenge in any case. They are already aware of this
problem and are busy in dealing with it. We look forward
to another exciting period of genomics research.
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